Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (32863)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 15, 2021 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nasa P, Chaudhary S, Shrivastava PK, Singh A. Euglycemic diabetic ketoacidosis: A missed diagnosis. World J Diabetes 2021; 12(5): 514-523 [PMID: 33995841 DOI: 10.4239/wjd.v12.i5.514] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i5/514.htm |
| Number | Citing Articles |
| 1 |
Andreas M. Nieß, Ansgar Thiel. Körperliche Aktivität und Trainingstherapie bei Typ-2-Diabetes – ein Update. Diabetologie und Stoffwechsel 2024; 19(01): 38 doi: 10.1055/a-1797-4949
|
| 2 |
Jonathan S. Auerbach, Hayley B. Gershengorn, Oscar D. Aljure, Joseph Lamelas, Samira S. Patel, Tanira D. Ferreira, Lazaro A. Gonzalez, Jorge L. Cabrera. Postcardiac Surgery Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Cotransporter 2 Inhibitors. Journal of Cardiothoracic and Vascular Anesthesia 2023; 37(6): 956 doi: 10.1053/j.jvca.2023.01.041
|
| 3 |
Rakahn Haddadin, Danny Aboujamra, Homayon Iraninezhad. Sodium-Glucose Cotransporter-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a Type 2 Diabetic Patient. Cureus 2023; doi: 10.7759/cureus.51184
|
| 4 |
Faical Jarraya, Abdou Niang, Hussein Bagha, Elliot Koranteng Tannor, Ernest Kiswaya Sumaili, Davy Ip Min Wan, Mogamat-Yazied Chothia, Yewondwossen Tadesse Mengistu, Francois Folefack Kaze, Ifeoma Isabella Ulasi, Saraladevi Naicker, Mohamed Hany Hafez, Kouame Hubert Yao. The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment Paradigm of CKD in Africa: An African Association of Nephrology Panel Position Paper. Kidney International Reports 2024; 9(3): 526 doi: 10.1016/j.ekir.2023.12.019
|
| 5 |
Paul Richard Edwin Jarvis. Euglycemic diabetic ketoacidosis: a potential pitfall for the emergency physician. Clinical and Experimental Emergency Medicine 2023; 10(1): 110 doi: 10.15441/ceem.22.410
|
| 6 |
Maximus Kyung Hyun Lee, Perry A. Ball. Euglycemic diabetic ketoacidosis in the setting of acute intracerebral hemorrhage. Surgical Neurology International 2024; 15: 284 doi: 10.25259/SNI_295_2024
|
| 7 |
William P. Martin, Niamh Reidy, Justin Low, Tomás Ahern. Case Report: Diabetic ketoacidosis after co-administration of empagliflozin and probenecid. Wellcome Open Research 2024; 8: 268 doi: 10.12688/wellcomeopenres.19148.2
|
| 8 |
Marutheesh Mallappa, Gayathri K Reddy, Murali Jayaraman. Euglycemic Diabetic Ketoacidosis—A Rare Cause for Delayed Extubation: Case Report. Indian Journal of Critical Care Case Report 2024; 3(3): 83 doi: 10.5005/jp-journals-11006-0105
|
| 9 |
Zhichao He, Kakei Lam, Wenxia Zhao, Shan Yang, Yu Li, Jiayao Mo, Siyuan Gao, Dan Liang, Kaifeng Qiu, Min Huang, Junyan Wu. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment. Acta Diabetologica 2022; 60(3): 401 doi: 10.1007/s00592-022-02015-6
|
| 10 |
Walter Yaw Agyeman, Inemesit Akpan, Kwasi Opare-Addo, Saheed Soleye, Alfred Solomon. Euglycemic Diabetic Ketoacidosis in a Patient Post Cardiac Surgery Receiving Continuous Renal-Replacement Therapy. Annals of Internal Medicine: Clinical Cases 2023; 2(10) doi: 10.7326/aimcc.2023.0663
|
| 11 |
João Fustiga, Marco Fernandes, Francisca Dâmaso, Joana A Duarte, Catarina Rodrigues. Postop Complication With Euglycemic Diabetic Ketoacidosis in a Patient Receiving Empagliflozin. Cureus 2022; doi: 10.7759/cureus.33161
|
| 12 |
Xiaoqing Xu, Dayang Wang, Huichai Pan, Jun Li, Bowu Li, Zhongchen He. Ketonuria in an adult with Prader-Willi syndrome and diabetes mellitus: A case report. Medicine 2024; 103(4): e37096 doi: 10.1097/MD.0000000000037096
|
| 13 |
Benjamin Cohen, Yael Tobi Harris, Rifka Schulman-Rosenbaum. Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia. Endocrine Practice 2024; 30(4): 402 doi: 10.1016/j.eprac.2023.11.014
|
| 14 |
Angelina Anthamatten. Important Dietary Considerations for Sodium-Glucose Cotransporter 2 Inhibitors. The Journal for Nurse Practitioners 2023; 19(3): 104527 doi: 10.1016/j.nurpra.2022.104527
|
| 15 |
Subodh Verma, Sunder Mudaliar, Peter J. Greasley. Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors. Advances in Therapy 2024; 41(1): 92 doi: 10.1007/s12325-023-02652-5
|
| 16 |
Beatrice C. Lupsa, Richard G. Kibbey, Silvio E. Inzucchi. Ketones: the double-edged sword of SGLT2 inhibitors?. Diabetologia 2023; 66(1): 23 doi: 10.1007/s00125-022-05815-1
|
| 17 |
Bianca-Liana Grigorescu. Dubito ergo sum. Pathologies that can mimic sepsis. The Journal of Critical Care Medicine 2022; 8(2): 77 doi: 10.2478/jccm-2022-0011
|
| 18 |
Sukhjinder Chauhan, AndreyI Manov, Gundip S Dhillon, Pinak Shah. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus. Cureus 2023; doi: 10.7759/cureus.33892
|
| 19 |
Sehui Kim, Dae-Lim Jee, Suyoun Chun, Jongyoon Baek. Utility of Partitioning of Standard Base Excess in Euglycemic Diabetic Ketoacidosis with Hyperchloremic Acidosis. Keimyung Medical Journal 2024; 43(1): 69 doi: 10.46308/kmj.2023.00248
|
| 20 |
Irina Balan, V Lakshmi N Priyanka Ganapathiraju, Sudha Dirisanala, Shafaq Taj, Pratikkumar Vekaria. Case Report: Euglycemic diabetic ketoacidosis led by empagliflozin: A case report and literature review. F1000Research 2022; 11: 1448 doi: 10.12688/f1000research.127382.1
|
| 21 |
Adnan Zaina, Nunzia Prencipe, Elena Golden, Alessandro Maria Berton, Eldad Arad, Ali Abid, Jeryes Shehadeh, Sameer Kassem, Ezio Ghigo. How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients. Endocrine 2023; 80(3): 491 doi: 10.1007/s12020-023-03352-4
|
| 22 |
Murat Dagdeviren, Tolga Akkan, Derun Taner Ertugrul. Re-emergence of a forgotten diabetes complication. Turkish Journal of Emergency Medicine 2024; 24(1): 1 doi: 10.4103/tjem.tjem_110_23
|
| 23 |
Hsiao-Hui Ju. Euglycemic Diabetic Ketoacidosis. Critical Care Nursing Clinics of North America 2024; doi: 10.1016/j.cnc.2024.08.004
|
| 24 |
Kyosuke Takahashi, Norimichi Uenishi, Masamitsu Sanui, Shigehiko Uchino, Naoki Yonezawa, Tetsuhiro Takei, Norihiro Nishioka, Hirotada Kobayashi, Shunichi Otaka, Kotaro Yamamoto, Hideto Yasuda, Shintaro Kosaka, Hidehiko Tokunaga, Naoki Fujiwara, Takashiro Kondo, Tomoki Ishida, Takayuki Komatsu, Koji Endo, Taiki Moriyama, Takayoshi Oyasu, Mineji Hayakawa, Atsumi Hoshino, Tasuku Matsuyama, Yuki Miyamoto, Akihiro Yanagisawa, Tadamasa Wakabayashi, Takeshi Ueda, Tetsuya Komuro, Toshiro Sugimoto, Alan Kawarai Lefor. Clinical profile of patients with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome in Japan: a multicenter retrospective cohort study. Acta Diabetologica 2023; 61(1): 117 doi: 10.1007/s00592-023-02181-1
|
| 25 |
Mohamad Ahangar Davoodi, Mohammad Ali Daneshmand, Taraneh Rezaei. Are sodium‐glucose cotransporter‐2 inhibitors safe adjunctive drugs during insulin therapy in young children with type 1 diabetes? The first case of type 1 diabetes with SLC5A2 mutation. Journal of Diabetes 2024; 16(7) doi: 10.1111/1753-0407.13570
|
| 26 |
Waiz Wasey, Sarah Hutchings, Anastasia Dufner, Dorathy Okon, Sharefi Saleh. Fall, Fracture, and Two Episodes of Euglycemic Diabetic Ketoacidosis. Cureus 2022; doi: 10.7759/cureus.25788
|
| 27 |
Feras Al-Moussally, Jung-Jung Tien, Kanya Rajagopalan, Carlos Boterosuarez, Roger Crouse. Euglycemic Ketoacidosis and Lactic Acidosis Associated With Metformin Toxicity. Cureus 2024; doi: 10.7759/cureus.60661
|
| 28 |
Guillermo E. Umpierrez, Georgia M. Davis, Nuha A. ElSayed, Gian Paolo Fadini, Rodolfo J. Galindo, Irl B. Hirsch, David C. Klonoff, Rozalina G. McCoy, Shivani Misra, Robert A. Gabbay, Raveendhara R. Bannuru, Ketan K. Dhatariya. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care 2024; 47(8): 1257 doi: 10.2337/dci24-0032
|
| 29 |
Guillermo E. Umpierrez, Georgia M. Davis, Nuha A. ElSayed, Gian Paolo Fadini, Rodolfo J. Galindo, Irl B. Hirsch, David C. Klonoff, Rozalina G. McCoy, Shivani Misra, Robert A. Gabbay, Raveendhara R. Bannuru, Ketan K. Dhatariya. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia 2024; 67(8): 1455 doi: 10.1007/s00125-024-06183-8
|
| 30 |
Inass Shaltout, Amr Mahmoud Abdelwahab, Amr El Meligi, Hany Hammad, Shereen Abdelghaffar, Atef Elbahry, Nasser Taha, Nehal Hamdy Elsaid, Amr Gad, Laila Hammouda, Shaymaa Abdelmaboud, Amin Roshdy Soliman. Risk Stratification in People with Diabetes for Fasting During Ramadan:
Consensus from Arabic Association for the Study of Diabetes and
Metabolism. Current Diabetes Reviews 2024; 20(7) doi: 10.2174/0115733998249793231005105724
|
| 31 |
Kripa Tiwari, Nava R Sharma, Madalasa Pokhrel, Arjun Basnet, Michael Kaplan. Misleading Presentation: Chest Pain Masking Euglycemic Diabetic Ketoacidosis Possibly Induced by Empagliflozin. Cureus 2023; doi: 10.7759/cureus.49402
|
| 32 |
Caroline Wojtas, Alex P. Rasarmos, Naja Naddaf, Wayne V. Moore. Sodium-Glucose Transport Protein 2 Inhibitors Association with Euglycemic Diabetic Ketoacidosis. Case Reports in Endocrinology 2023; 2023: 1 doi: 10.1155/2023/6835882
|
| 33 |
Bibek Devkota, Timothy Maxwell, Jessica Schaedel, Brant M Wagener, Weifeng Song, Nishank Patel Nooli. Intraoperative Diagnosis of Sodium-Glucose Transporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis. Cureus 2024; doi: 10.7759/cureus.71931
|
| 34 |
Ivana Novaković, Jovana Todorović, Stefan Dugalić, Maja Macura, Miloš Milinčić, Miroslava Gojnić. Diabetic ketoacidosis in pregnancy. Sanamed 2024; 19(2): 221 doi: 10.5937/sanamed0-50195
|
| 35 |
Almurtada Razok, Fateen Ata, Sara Mohamed Ibrahim Ahmed, Dabia Hamad S H Al Mohanadi. Sodium-glucose co-transporter 2 inhibitors induced euglycemic diabetic ketoacidosis within four days of initiation. World Journal of Diabetes 2022; 13(3): 272-274 doi: 10.4239/wjd.v13.i3.272
|
| 36 |
Shejil Kumar, Terrence Diamond. Ramadan Fasting and Maternal and Fetal Outcomes in Pregnant Women with Diabetes Mellitus: Literature Review. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.900153
|
| 37 |
Shahd M. Abbas, Fajr Jamal A.bagi, Asmaa Abdalkarim, Nematalla Sabir Balla, Amro Abdelrahman, Khalid Y Fadul. Case Report: Chest Pain as an Uncommon Presentation for Euglycemic Diabetic Ketoacidosis in a Female Patient Using SGLT2 inhibitor. F1000Research 2024; 12: 1157 doi: 10.12688/f1000research.139928.2
|
| 38 |
Myrem Jesame F Sarno, Dan Philip F Hernandez, Melgar O Matulac. "Normal but Catastrophic” Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report. Cureus 2023; doi: 10.7759/cureus.49236
|
| 39 |
Andrijana Koceva, Nika Aleksandra Kravos Tramšek. From Sweet to Sour: SGLT-2-Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Journal of Personalized Medicine 2024; 14(7): 665 doi: 10.3390/jpm14070665
|
| 40 |
Věra Čertíková Chábová, Oskar Zakiyanov. Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes. International Journal of Molecular Sciences 2022; 23(5): 2812 doi: 10.3390/ijms23052812
|
| 41 |
Erica Chow, Stephen Clement, Rajesh Garg. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Research & Care 2023; 11(5): e003666 doi: 10.1136/bmjdrc-2023-003666
|
| 42 |
Cameron Widhalm, Victor Pulido. Euglycemic Diabetic Keto Acidosis in a Type 1 Diabetic Patient After Glucose Like Peptide-1 Administration: A Case Presentation. Journal of Investigative Medicine High Impact Case Reports 2023; 11 doi: 10.1177/23247096231206333
|
| 43 |
Hesham Yasin, Jordan D. Ross, James Turner, Samuel Dagogo-Jack. Euglycemic Diabetic Ketoacidosis in a Pregnant Patient on Insulin Pump Therapy. AACE Clinical Case Reports 2024; doi: 10.1016/j.aace.2024.10.004
|
| 44 |
Mei-An Pai, Tsai-Kun Wu, Shiaw-Wen Chien, Chang-Hsu Chen, Yuan-Chuan Kuo, Hung-Ping Chen, Tien-Yu Tseng, Paik-Seong Lim. Euglycemic diabetic ketoacidosis associated with sodium–glucose cotransporter-2 inhibitors after surgery: A case report and review of literature. Tungs' Medical Journal 2023; 17(2): 85 doi: 10.4103/ETMJ.ETMJ-D-23-00018
|
| 45 |
Jens Aberle, Matthias Blüher, Matthias Laudes, Martin Merkel, Petra Sandow. SGLT-2-Inhibitoren – Eine Standortbestimmung in der deutschen oralen Therapielandschaft für Menschen mit Typ-2-Diabetes. Diabetologie und Stoffwechsel 2024; doi: 10.1055/a-2435-6818
|
| 46 |
Benjamin Steinhorn, Jeanine Wiener-Kronish. Dose-dependent relationship between SGLT2 inhibitor hold time and risk for postoperative anion gap acidosis: a single-centre retrospective analysis. British Journal of Anaesthesia 2023; 131(4): 682 doi: 10.1016/j.bja.2023.06.063
|
| 47 |
Yuichiro Arima. The Impact of Ketone Body Metabolism on Mitochondrial Function and Cardiovascular Diseases. Journal of Atherosclerosis and Thrombosis 2023; 30(12): 1751 doi: 10.5551/jat.RV22011
|
| 48 |
Matthew F Hillock, Cierra Jarmon, Anastasia E Metropulos, Rachael King, Stefan Tchernodrinski, Daniel R Principe. Diabetic ketoacidosis masked by both Euglycemia and a primary metabolic alkalosis. Oxford Medical Case Reports 2024; 2024(7) doi: 10.1093/omcr/omae071
|
| 49 |
N. Silvestris, T. Franchina, M. Gallo, A. Argentiero, A. Avogaro, G. Cirino, A. Colao, R. Danesi, G. Di Cianni, S. D’Oronzo, A. Faggiano, S. Fogli, D. Giuffrida, S. Gori, N. Marrano, R. Mazzilli, M. Monami, M. Montagnani, L. Morviducci, A. Natalicchio, A. Ragni, V. Renzelli, A. Russo, L. Sciacca, E. Tuveri, M.C. Zatelli, F. Giorgino, S. Cinieri. Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper. ESMO Open 2023; 8(6): 102062 doi: 10.1016/j.esmoop.2023.102062
|
| 50 |
Audrey K. Cook, Ellen Behrend. SGLT2 inhibitor use in the management of feline diabetes mellitus. Journal of Veterinary Pharmacology and Therapeutics 2024; doi: 10.1111/jvp.13466
|
| 51 |
Zhaoxiang Liu, Luqi Xiao, Chenxi Jin, Jianzhong Xiao, Wenhui Zhao. Euglycaemic Ketoacidosis Due to Extremely Low-Calorie Intake and Dehydration After Laparoscopic Sleeve Gastrectomy in a Patient with Type 2 Diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 2377 doi: 10.2147/DMSO.S373712
|
| 52 |
Beng Leong Lim, Kee Vooi Loo, Wei Feng Lee. Euglycemic diabetic ketoacidosis: pitfalls, challenges, and perspectives in emergency medicine. European Journal of Emergency Medicine 2024; doi: 10.1097/MEJ.0000000000001189
|
| 53 |
Jinyoung Kim, Yeoree Yang, Chaiho Jeong, Ba-Ron Yang, Mee Kyoung Kim, Seung-Hwan Lee, Ki-Ho Song. Case 11: A 31-Year-Old Woman With Abdominal Pain. Journal of Korean Medical Science 2023; 38(23) doi: 10.3346/jkms.2023.38.e206
|
| 54 |
Azeem Rathore, Nidhi Gupta, Cameron Kahn. Euglycemic diabetic ketoacidosis caused by Empagliflozin complicated by failure to thrive in a geriatric patient. Archive of Clinical Cases 2023; 10(2): 89 doi: 10.22551/2023.39.1002.10248
|
| 55 |
Antoine Hedary, Lacie Melder, Micah Pippin . A Case of Euglycemic Diabetic Ketoacidosis Associated With a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. Cureus 2024; doi: 10.7759/cureus.75399
|
| 56 |
Esraa Mamdouh Hassan, Hisham Mushtaq, Esraa Elaraby Mahmoud, Sherley Chhibber, Shoaib Saleem, Ahmed Issa, Jain Nitesh, Abbas B Jama, Anwar Khedr, Sydney Boike, Mikael Mir, Noura Attallah, Salim Surani, Syed A Khan. Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state. World Journal of Clinical Cases 2022; 10(32): 11702-11711 doi: 10.12998/wjcc.v10.i32.11702
|
| 57 |
Carol F. Kirkpatrick, Anandita Agarwala, Kevin C. Maki. How low should one go in reducing carbohydrate?. Journal of Clinical Lipidology 2022; 16(6): 769 doi: 10.1016/j.jacl.2022.10.007
|
| 58 |
Mackenzi Meier, Benedicta Ansong, Dolapo Awobusuyi, Raven Lee-Oyagha, Sarah Lopez. Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor-Related Euglycemic Diabetic Ketoacidosis: A Case Series. Journal of Pharmacy Practice 2025; 38(1): 193 doi: 10.1177/08971900241273169
|
| 59 |
Brannon Inman, Joseph K. Maddry, Patrick C. Ng, Alex Koyfman, Brit Long. High risk and low prevalence diseases: Toxic alcohol ingestion. The American Journal of Emergency Medicine 2023; 67: 29 doi: 10.1016/j.ajem.2023.01.048
|
| 60 |
Antonia-Therese Kietaibl, Peter Fasching, Karl Glaser, Alexander H. Petter-Puchner. New Diabetic Medication Sodium-Glucose Cotransporter-2 Inhibitors Can Induce Euglycemic Ketoacidosis and Mimic Surgical Diseases: A Case Report and Review of Literature. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.828649
|
| 61 |
Jingjing Han, Shuo Xie, Hongmei Jiao. Sodium‐glucose cotransporter‐2 inhibitor‐induced euglycemic diabetic ketoacidosis: A case report. Journal of Clinical Pharmacy and Therapeutics 2022; 47(9): 1482 doi: 10.1111/jcpt.13737
|
| 62 |
Ankia Coetzee, David R. Hall, Eduard J. Langenegger, Mari van de Vyver, Magda Conradie. Pregnancy and diabetic ketoacidosis: fetal jeopardy and windows of opportunity. Frontiers in Clinical Diabetes and Healthcare 2023; 4 doi: 10.3389/fcdhc.2023.1266017
|
| 63 |
Carmela Morace, Giuseppe Lorello, Federica Bellone, Cristina Quartarone, Domenica Ruggeri, Annalisa Giandalia, Giuseppe Mandraffino, Letteria Minutoli, Giovanni Squadrito, Giuseppina T. Russo, Herbert Ryan Marini. Ketoacidosis and SGLT2 Inhibitors: A Narrative Review. Metabolites 2024; 14(5): 264 doi: 10.3390/metabo14050264
|
| 64 |
. Rizwanullah, Tahera Ahmadi, Aftab Ahmad, Waqar Khan, Jose C Rosario-Curcio. Euglycemic Diabetic Ketoacidosis With Acute Renal Failure: A Challenging Case for Clinicians. Cureus 2024; doi: 10.7759/cureus.60171
|
| 65 |
Nadeem Rais, Rizwan Ahmad, Akash Ved, Kehkashan Parveen, Darakhshan Gazala Bari, Om Prakash. Diabetic Ketoacidosis (DKA), a Leading Risk Factor for Mucormycosis
(Black Fungus), during the Era of Coronavirus Disease-2019 (COVID-19):
An Overview. Current Diabetes Reviews 2023; 19(1) doi: 10.2174/1573399818666220315162424
|
| 66 |
Nevin Kamal, Kristen Lee, Grazia Aleppo. Newer Outpatient Diabetes Therapies and Technologies. Medical Clinics of North America 2024; 108(5): 923 doi: 10.1016/j.mcna.2024.03.002
|
| 67 |
Vania Benido Silva, Liliana Fonseca, Diana Borges Duarte, Francisca Marques Puga, Guilherme Assuncao, Susana Garrido, Sofia Teixeira, Joana Vilaverde, Maria Helena Cardoso. Efficacy and safety of SGLT2 inhibitors in individuals with type 1 diabetes under continuous subcutaneous insulin infusion: a real-world study. Endocrine Regulations 2023; 57(1): 144 doi: 10.2478/enr-2023-0018
|
| 68 |
Tiffany Corlin, Sereen K. Nashif, Katelyn M. Tessier, Megan Kristan, W. Kirke Rogers, Sarah A. Wernimont. Opportunities to Improve Recognition of Diabetic Ketoacidosis in Pregnancy. O&G Open 2024; 1(4): 035 doi: 10.1097/og9.0000000000000035
|
| 69 |
Arnon Gal, Adesola Odunayo. Diabetes Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome in Companion Animals. Veterinary Clinics of North America: Small Animal Practice 2023; 53(3): 531 doi: 10.1016/j.cvsm.2023.01.005
|
| 70 |
Christopher D VonTungeln, Mohammad Al Bataineh. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report. Cureus 2024; doi: 10.7759/cureus.52122
|
| 71 |
Shahd M. Abbas, Fajr Jamal A.bagi, Asmaa Abdalkarim, Nematalla Sabir Balla, Amro Abdelrahman, Khalid Y Fadul. Case Report: Chest Pain as an Uncommon Presentation for Euglycemic Diabetic Ketoacidosis in a Female Patient Using SGLT2 inhibitor. F1000Research 2023; 12: 1157 doi: 10.12688/f1000research.139928.1
|
| 72 |
Dimitra Stathi, Ketan K. Dhatariya, Omar G. Mustafa. Management of diabetes‐related hyperglycaemic emergencies in advanced chronic kidney disease: Review of the literature and recommendations. Diabetic Medicine 2024; doi: 10.1111/dme.15405
|
| 73 |
Huaxi Zou, Baiquan Qiu, Jichun Liu. Alexander et al.: Longer-Term Effects of SGLT2Is. Journal of General Internal Medicine 2022; 37(11): 2870 doi: 10.1007/s11606-022-07655-6
|
| 74 |
Fatemeh Mohammadzade, Behnaz Khodabakhshi, Elahe Amiri, Amir Bigdeli, Fahimeh Abdollahi, Alireza Fatemi. Euglycemic diabetic ketoacidosis and COVID‐19 management in a term pregnant patient; a case report. Clinical Case Reports 2022; 10(12) doi: 10.1002/ccr3.6705
|
| 75 |
Yee Wen Kong, Dale Morrison, Jean C. Lu, Melissa H. Lee, Alicia J. Jenkins, David N. O'Neal. Continuous ketone monitoring: Exciting implications for clinical practice. Diabetes, Obesity and Metabolism 2024; 26(S7): 47 doi: 10.1111/dom.15921
|
| 76 |
Enrique Chicote-Álvarez, Helena Camino-Ferró, Isabel Mainar-Gil, Lucía Ángela Vilella-Llop, Mirian Ruiz de la Cuesta-López, Natalia Gloria Lizama-Gómez. Cetoacidosis diabética euglucémica en paciente gestante con infección por SARS-CoV-2: reporte de caso. Acta Colombiana de Cuidado Intensivo 2023; 23(1): 78 doi: 10.1016/j.acci.2022.09.002
|
| 77 |
Gao Wu, Shuxie Wu, Jin Tang, Hanbin Wu. Delayed euDKA Associated With Dapagliflozin After Pancreatitis. Clinical Therapeutics 2023; 45(7): e167 doi: 10.1016/j.clinthera.2023.05.006
|
| 78 |
Fiona Bensoussan, Guillaume Costa, Anne Blanchard, Isabelle Vaugier, Stéphanie Baron, Aben Essid, Blaise Mbieleu, Awa Bakayoko, Nicolas Deconinck, Jean Bergounioux, Justine Zini. Paradoxical metabolic acidosis after vomiting in children with spinal muscular atrophy: A report of 9 patients. Archives de Pédiatrie 2024; 31(7): 451 doi: 10.1016/j.arcped.2024.03.010
|
| 79 |
Jessica Warffuel, Linda Barbour, Shannon Son. Diabetic Ketoacidosis and Euglycemic Diabetic Ketoacidosis in Pregnancy. Topics in Obstetrics & Gynecology 2024; 44(3): 1 doi: 10.1097/01.PGO.0001006384.17611.04
|
| 80 |
Rabia Salman Mahfooz, Muhammad Khuzzaim Khan, Hussam Al Hennawi, Anwar Khedr. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review . Cureus 2022; doi: 10.7759/cureus.26267
|
| 81 |
Sukhjinder Chauhan, Victoria Diaz, Ikechukwu R Ogbu, Justin Roy P Sanchez, Andre E Manov, Pinak Shah. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis Masked by Urinary Tract Infection. Cureus 2024; doi: 10.7759/cureus.66408
|
| 82 |
Muhammad Sameer Arshad, Adeena Jamil, Stephen J. Greene, Harriette G.C Van Spall, Gregg C. Fonarow, Javed Butler, Muhammad Shahzeb Khan. In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure. Heart Failure Reviews 2024; 30(1): 89 doi: 10.1007/s10741-024-10446-2
|
| 83 |
Bobbi-Jo Lowie, Michael C. Bond. Diabetic Ketoacidosis. Emergency Medicine Clinics of North America 2023; 41(4): 677 doi: 10.1016/j.emc.2023.06.002
|
| 84 |
Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa, Muhammad Tukur Ibrahim. Design of some potent non-toxic Autoimmune disorder inhibitors based on 2D-QSAR, CoMFA, molecular docking, and molecular dynamics investigations. Intelligent Pharmacy 2024; 2(5): 688 doi: 10.1016/j.ipha.2023.12.009
|
| 85 |
Beda M. Cha, Roland Davoudi, Michael C. DiVita, Ashley M. Fan, Megan Y. Kamath. Sodium-Glucose Cotransporter-2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings 2021; 53(8): 2636 doi: 10.1016/j.transproceed.2021.08.017
|